BETRBETTERLIFE PHARMA INC.
0.2400CAD+4.35%Mkt Cap: 34.26M $P/E:

BetterLife Pharma Inc., a biotechnology company, engages in the development of psychedelic-derived compounds. It focuses on developing and commercializing BETR-001, a non-hallucinogenic and non-controlled LSD derivative …

Key Statistics

Company
Market Cap34.26M $
Enterprise Value40.21M $
Revenue (TTM)
Gross Profit
Net Income (TTM)-1.09M $
Revenue/Share
Last Price0.2400 CAD
Fiscal Year EndJan 2026
MR QuarterApr 2026
Employees
CountryCA
SectorHealthcare
IndustryBiotechnology
ISINCA08772P2026
Valuation
P/E (Trailing)
P/E (Forward)
PEG
EV/EBITDA
EV/Revenue
P/S
P/B-5.25
EPS (TTM)-0.01
EPS (Forward)
52W Range
0.040095% of range0.2500
52W High0.2500 CAD
52W Low0.0400 CAD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE15.28%
ROA-680.07%
Growth
Revenue Growth
Earnings Growth
Cash Flow & Leverage
Operating CF-455.49K $
CapEx (TTM)
FCF Margin
FCF Yield-1.46%
Net Debt677.88K $
Net Debt/EBITDA
Balance Sheet
Debt/Equity-0.13
Current Ratio0.04
Quick Ratio0.01
Book Value/Sh-0.0600 CAD
Cash/Share0.0000 CAD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 CAD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split1:10
Split DateJun 26, 2020
Analyst Consensus
Rating
Target (Mean)
Target Range
# Analysts
Ownership
Shares Out.164.89M
Float106.71M
Insiders32.49%
Institutions0.00%
Short Interest
Short Ratio0.2d
Short % Float0.05%
Short % Out.0.03%
Shares Short52.34K
Short (prev mo.)11.43K
Technical
SMA 500.2042 (+17.5%)
SMA 2000.0950 (+152.5%)
Beta0.22
S&P 52W Chg18.16%
Avg Vol (30d)249.66K
Avg Vol (10d)343.58K
Technical Indicators
RSI (14)68.1
MACD0.0283
MACD Signal0.0309
MACD Hist.-0.0026
BB Upper0.2522 CAD
BB Middle0.2132 CAD
BB Lower0.1743 CAD
BB Width36.55%
ATR (14)0.0190 CAD
Vol Ratio (20d)0.21x